The United Kingdom remains one of Europe’s most influential and scientifically advanced life sciences markets. However, the regulatory landscape has evolved significantly in recent years, creating new national requirements, processes and expectations that differ from the EU framework. Navigating this environment successfully requires dedicated expertise and continuous oversight. Our experts are well versed in this task.
Whether you are planning entry into the UK market or overseeing an existing portfolio, our UK regulatory experts offer bespoke support throughout the entire product lifecycle – from early-stage development and submission strategy through to marketing authorisations and ongoing post-approval maintenance.
We can operate either as an external partner, delivering clearly defined work packages, or as an extension of your internal team, enhancing your regulatory capabilities where needed.
Drawing on extensive practical experience with MHRA procedures, we ensure your UK regulatory activities are both strategically coordinated and executed with efficiency.
Lovisa Rosenquist
Staffan Thunell
Founding partner
BSc Economics and BA
Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from positions as Founder, Chairman, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.